Managing pregnancy in a patient with Von Willebrand disease: a case report of tailored hemostatic care

A hemostatic condition known as Von Willebrand disease (VWD) is defined by a quantitative or qualitative deficit of the Von Willebrand factor (VWF). Both men and women are equally impacted. With a mean diagnostic age of 19 years old, this illness presents with more severe clinical signs in females of reproductive age. Von Willebrand disease in­crea­ses the chance of postpartum hemorrhage and its as­so­cia­ted complications from transfusion support and mul­ti­organ injury from tissue hypoperfusion in pregnant pa­tients. These factors increase the risk of complications du­ring labor or the postpartum period. We describe the case of a 35-year-old primigravida woman who had Von Wille­brand disease diagnosed before she became pregnant. While not administered, the institutional procedure for ad­dres­sing this condition included obtaining and being ready for the administration of Von Willebrand factor and fac­tor VIII (FVIII) throughout the postpartum period and cae­sa­rean birth. With an increase in Von Willebrand factor levels, this led to the successful management of prenatal and postpartum hemorrhage, preventing the need for blood trans­fu­sions and the subsequent hypoperfusion symp­toms. The importance of specialist therapy for Von Wille­brand disease during pregnancy and childbirth is shown by this instance, which also highlights the need of following in­sti­tu­tio­nal procedures, including certain he­mo­sta­tic agents. For the thorough care of females with this illness through­out the perinatal period, the cooperative ef­forts of a mul­ti­dis­ci­pli­nary team, comprising obstetricians, he­ma­to­lo­gists and other medical specialists, are essential.